CD15 MicroBeads, human

CD15 MicroBeads were developed for positive selection or depletion of CD15+ cells from human lysed peripheral blood or single-cell suspensions from tissues.

qualityAssuranceSatisfaction
guaranteed
more »

Related products for CD15 MicroBeads, human

Specifications for CD15 MicroBeads, human
Overview

CD15 MicroBeads were developed for positive selection or depletion of CD15+ cells from human lysed peripheral blood or single-cell suspensions from tissues.

Detailed product information
Background information

The CD15 antibody recognizes a 3-fucosyl-N-acetyllactosamine carbohydrate modification in glycolipids or glycoproteins. The CD15 antigen is expressed on neutrophils, eosinophils, and monoblastoid precursor cells of the myeloid lineage but not on basophils and lymphocytes. The antigen is also present on Hodgkin/Reed-Sternberg cells.

Downstream applications

CD15 MicroBeads are used for the isolation1 or depletion of human eosinophils and neutrophils (basophils are CD15-) from peripheral blood and from tissues such as ovarian carcinoma tissue.2 Furthermore, CD15 MicroBeads can be used for the depletion of myeloid cells from bone marrow.

Columns

For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.

Product data and images for CD15 MicroBeads, human
Figure 1

CD15+ cells were isolated from lysed human peripheral blood using CD15 MicroBeads,

an MS Column, and a MiniMACS™ Separator. Cells are fluorescently stained with CD15-FITC.

Citations for CD15 MicroBeads, human
Publications
  1. Zahler, S. et al. (1997) The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. J. Immunol. Methods 200: 173-179
  2. Harbeck, N. et al. (1995) Model system for isolation of competent ovarian-carcinoma cells from fresh tumor-tissue by a magnetic separation technique (MACS). Int. J. Oncol. 6: 1249-1254

You have previously chosen International as your location.
What do you want to do?